Galectin Therapeutics (PHPN.F) Q4 2024 Earnings

14NovConfirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-0.19
-0.18
-0.16
-0.15

Details

Expected EPS
-0.189932
Actual EPS
-0.17093879999999997
Surprise EPS
0.02
Surprise Percent
+10%

Description

Galectin Therapeutics (PHPN.F) has reported earnings of -0.17093879999999997 per share for Q4 2024.

0 Comments

Share your thoughts